First Trust NYSE Arca Biotechnology Index Fund 

$214.47
26
+$1.54+0.72% Monday 21:00

Statistics

Day High
214.91
Day Low
211.1
52W High
224.94
52W Low
141.38
Volume
75,512
Avg. Volume
157,406
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
Dec 24
$1.17
Sep 15
$0.02
Jun 15
$0.06
Mar 15
$0.05
Dec 14
$0.05
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow FBT. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
iShares Biotechnology
IBB
Mkt Cap0
iShares Nasdaq Biotechnology ETF is a direct competitor, focusing on biotechnology and pharmaceuticals, similar to FBT, with a broad exposure to these sectors.
State Street SPDR S&P Biotech
XBI
Mkt Cap0
SPDR S&P Biotech ETF offers exposure to the biotech sector, directly competing with FBT by investing in biotechnology companies.
VanEck Biotech
BBH
Mkt Cap0
VanEck Vectors Biotech ETF is a competitor because it also targets the biotechnology industry, offering similar exposure to companies in the biotech sector.
Invesco Biotechnology & Genome
PBE
Mkt Cap0
Invesco Dynamic Biotechnology & Genome ETF competes by investing in biotech and genome companies, similar to FBT's focus on the biotech industry.
Virtus LifeSci Biotech Products
BBP
Mkt Cap0
Virtus LifeSci Biotech Products ETF is a competitor as it focuses on biotechnology product companies, closely aligning with FBT's investment strategy.
ALPS Medical Breakthroughs
SBIO
Mkt Cap0
ALPS Medical Breakthroughs ETF is a competitor because it invests in small and mid-cap biotechnology and pharmaceutical companies, similar to FBT's investment approach.
Fortress Biotech
FBIO
Mkt Cap76.17M
Franklin Genomic Advancements ETF competes by focusing on companies involved in genomics and biotechnology, offering a similar thematic investment to FBT.
Global X Genomics & Biotechnology
GNOM
Mkt Cap0
Global X Genomics & Biotechnology ETF is a competitor as it focuses on the genomics industry, overlapping with FBT's biotech investment theme.
iShares Genomics Immunology and Healthcare
IDNA
Mkt Cap0
iShares Genomics Immunology and Healthcare ETF competes by investing in companies that could benefit from the long-term growth and innovation in genomics, immunology, and biotechnology, similar to FBT's focus.

About

The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depositary receipts that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of a cross section of small, mid and large capitalization companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services.
Show more...
CEO
Country
US
ISIN
US33733E2037

Listings

0 Comments

Share your thoughts

FAQ

What is First Trust NYSE Arca Biotechnology Index Fund stock price today?
The current price of FBT is $214.47 USD — it has increased by +0.72% in the past 24 hours. Watch First Trust NYSE Arca Biotechnology Index Fund stock price performance more closely on the chart.
What is First Trust NYSE Arca Biotechnology Index Fund stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange First Trust NYSE Arca Biotechnology Index Fund stocks are traded under the ticker FBT.
Is First Trust NYSE Arca Biotechnology Index Fund stock price growing?
FBT stock has fallen by -2.37% compared to the previous week, the month change is a +3.25% rise, over the last year First Trust NYSE Arca Biotechnology Index Fund has showed a +20.01% increase.
Does First Trust NYSE Arca Biotechnology Index Fund pay dividends?
Yes, FBT dividends are paid quarterly. The last dividend per share was 1.17 USD. As of today, Dividend Yield (FWD)% is 0%.
When did First Trust NYSE Arca Biotechnology Index Fund complete a stock split?
First Trust NYSE Arca Biotechnology Index Fund has not had any recent stock splits.